Abstract
Initiation and promotion have been recognized as essential parts of the multi-stage concept of chemical carcinogenesis. In the liver, initiation by genotoxic carcinogens results in appearance of foci of phenotypically altered hepatocytes. Accelerated growth and phenotypic changes of these foci during tumor promotion by phenobarbital are described, and possible mechanisms of initiation and promotion considered.
Similar content being viewed by others
References
Bannasch P, Moore MA, Klimek F, Zerban H (1982) Biological markers of preneoplastic foci and neoplastic nodules in rodent liver. Toxicol Pathol 10: 19–36
Bannasch P, Hacker HJ, Klimek F, Mayer D (1984) Hepatocellular glycogenesis and related pattern of enzymatic changes during hepatocarcinogenesis. In: Weber G (ed) Advances in enzyme regulation. Vol 22. Pergamon Press, Oxford New York
Boutwell RK (1974) The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol 2: 419–443
Bursch W, Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J, Schuhe-Hermann R (1984) Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5: 453–458
Farber E, Cameron R (1980) The sequential analysis of cancer development. Adv Cancer Res 31: 125–225
Hecker E (1978) Co-carcinogene oder bedingt krebsauslösende Faktoren. Aktuelle neue Aspekte der Ätiologie menschlicher Tumoren und des molekularen Mechanismus der Krebsentstehung. Naturwissenschaften 65: 640–648
Klein G, Klein E (1985) Evolution to tumours and the impact of molecular oncology. Nature 315: 190–195
Pitot HC, Sirica AE (1980) The stages of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta 605: 191–215
Reinacher M, Eigenbrodt E, Gerbracht U, Zenk G, Timmer mann-Trosiener I, Bentley P, Waechter F, Schoner W, Schulte-Hermann R (1986) Pyruvate kinase isoenzymes in altered foci and carcinoma of rat liver. Carcinogenesis 7: 1351–1357
Remmer H, Merker HJ (1963) Drug-induced changes in the liver endoplasmic reticulum: association with drug-metabolizing enzymes. Science 142: 1657–1658
Rutenberg AM, Kim H, Fischbein J, Hauker JS, Wasserkrug HC, Seligman R (1968) Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase activity. J Histochem Cytochem 17: 517–526
Schulte-Hermann R (1974) Induction of liver growth by xenobiotic compounds and other stimuli. Crit Rev Toxicol 3: 97–158
Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J (1982) Response of liver foci in rats to hepatic tumor promoters. Toxicol Pathol 10: 63–70
Schulte-Hermann R, Roome N, Timmermann-Trosiener I, Schuppler J (1984a) Immunocytochemical demonstration of a phenobarbital-inducible cytochrome P450 in putative preneoplastic foci of rat liver. Carcinogenesis 5: 149–153
Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J (1984b) Aberrant expression of adaption to phenobarbital may cause selective growth of foci of altered cells in rat liver. In: Börzsony M, Lapis K, Day NE, Yamasaki H (eds) Models, mechanisms and etiology of tumor promotion. IARC Scientific Publication, Vol 56, pp 67–75
Schulte-HermannR (1985) Tumor promotion in the liver. Arch Toxicol 57: 147–158
Stäubli W, Bentley P, Bieri F, Fröhlich E, Waechter F (1984) Inhibitory effect of nafenopin upon the development of diethylnitrosamine-induced enzyme-altered foci within the rat liver. Carcinogenesis 5: 41–47
Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M (1985) Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 315: 382–385
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. med. Herbert Remmer on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Schulte-Hermann, R. Initiation and promotion in hepatocarcinogenesis. Arch Toxicol 60, 179–181 (1987). https://doi.org/10.1007/BF00296976
Issue Date:
DOI: https://doi.org/10.1007/BF00296976